Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

363
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Sustainable Development01:43

Sustainable Development

15.2K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

3.5K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.5K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

2.7K
Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.7K
The Cardiac Cycle01:13

The Cardiac Cycle

98.5K
The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
98.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmaceutical quality and cost-effectiveness of branded versus generic medicines across 22 drug types and 8 therapeutic categories: a citizen-funded comparative study from regulated retail outlets in Kerala, India.

Frontiers in pharmacology·2026
Same author

Optimization of extrusion-based production of Wharton's jelly MSC-derived nanovesicles.

Tissue & cell·2026
Same author

Role of Extracellular Vesicles in Skin Barrier Repair: Applications in Atopic Dermatitis and Chronic Wounds.

International journal of nanomedicine·2026
Same author

Phenotypic profiling of neutrophils in acute <i>Clostridioides difficile</i> infection identifies a TNF-induced activation signature associated with epithelial damage.

Gut microbes·2026
Same author

3D-Bioprinted Gelatin Hydrogels with Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Cutaneous Wound Healing In Vivo.

Polymers·2026
Same author

Low oxygen preconditioning of umbilical cord MSCs: from biological to mechanistic innovation.

Journal of translational medicine·2026

Related Experiment Video

Updated: Feb 8, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
08:19

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes

Published on: June 22, 2020

7.1K

Development of an In Vitro Cardiac Ischemic Model Using Primary Human Cardiomyocytes.

Pezhman Hafez1, Shiplu R Chowdhury1, Shinsmon Jose2

  • 1Tissue Engineering Centre, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000, Kuala Lumpur, Malaysia.

Cardiovascular Engineering and Technology
|June 28, 2018
PubMed
Summary
This summary is machine-generated.

This study developed an in vitro model for ischemic heart disease using human cardiomyocytes (HCM) under hypoxia and re-oxygenation. The model effectively simulates myocardial injury and allows for studying potential therapeutic interventions.

Keywords:
Cardiac ischemic modelHypoxia/re-oxygenationMitochondrial transferPrimary human cardiomyocytesReperfusion injury

More Related Videos

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.4K
A Triple Primary Cell Culture Model of the Human Blood-Brain Barrier for Studying Ischemic Stroke In Vitro
11:06

A Triple Primary Cell Culture Model of the Human Blood-Brain Barrier for Studying Ischemic Stroke In Vitro

Published on: October 6, 2022

4.7K

Related Experiment Videos

Last Updated: Feb 8, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
08:19

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes

Published on: June 22, 2020

7.1K
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.4K
A Triple Primary Cell Culture Model of the Human Blood-Brain Barrier for Studying Ischemic Stroke In Vitro
11:06

A Triple Primary Cell Culture Model of the Human Blood-Brain Barrier for Studying Ischemic Stroke In Vitro

Published on: October 6, 2022

4.7K

Area of Science:

  • Cardiovascular Research
  • Cellular Biology
  • Biomedical Engineering

Background:

  • Ischemic heart disease necessitates robust experimental models for mechanistic understanding and therapeutic development.
  • Current models often lack the complexity to fully replicate in vivo conditions of cardiomyocyte injury.

Purpose of the Study:

  • To establish a reliable in vitro model of cardiac ischemia using primary human cardiomyocytes (HCM).
  • To characterize the cytotoxic effects and optimal parameters for hypoxia/re-oxygenation in this model.
  • To assess the potential of this model for studying therapeutic interventions, such as stem cell applications.

Main Methods:

  • Primary human cardiomyocytes (HCM) were subjected to varying durations of hypoxia (1% O2) followed by re-oxygenation.
  • Hypoxia Inducible Factor 1α (HIF-1α) expression was used to determine optimal hypoxic time.
  • Mitochondrial injury (MTT assay) and cytotoxicity (LDH assay) were measured to define optimal re-oxygenation periods.
  • Mesenchymal stem cell interactions with ischemic HCM were observed.

Main Results:

  • 3 hours of hypoxia optimally stimulated HIF-1α expression in HCM.
  • 6 hours of re-oxygenation induced significant, reversible mitochondrial injury and cytotoxicity.
  • Irreversible injury occurred after 9 hours of re-oxygenation, indicated by >60% LDH leakage.
  • Mesenchymal stem cells formed nanotubes with ischemic HCM, transferring mitochondria.

Conclusions:

  • The developed in vitro model accurately mimics key aspects of myocardial ischemia and reperfusion injury.
  • This model provides a platform for investigating molecular mechanisms of cardiac injury and evaluating rescue strategies.
  • The observed stem cell-mediated mitochondrial transfer highlights potential therapeutic avenues for ischemic heart disease.